14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $30.91 $39.58 Friday, 3rd May 2024 ARVN stock ended at $32.82. This is 1.20% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.03% from a day low at $32.65 to a day high of $33.97.
90 days $30.91 $53.08
52 weeks $13.57 $53.08

Historical Arvinas Inc. prices

Date Open High Low Close Volume
May 03, 2024 $33.80 $33.97 $32.65 $32.82 415 371
May 02, 2024 $33.12 $33.12 $31.69 $32.43 608 586
May 01, 2024 $31.85 $33.21 $31.35 $32.48 685 899
Apr 30, 2024 $31.50 $32.18 $31.15 $31.77 1 199 689
Apr 29, 2024 $32.23 $32.62 $31.46 $31.90 846 407
Apr 26, 2024 $31.73 $32.72 $31.04 $32.37 765 540
Apr 25, 2024 $32.00 $32.13 $30.91 $31.60 618 904
Apr 24, 2024 $33.82 $33.83 $32.52 $32.54 452 993
Apr 23, 2024 $34.86 $35.58 $33.90 $34.00 522 589
Apr 22, 2024 $34.80 $35.87 $34.52 $34.90 835 950
Apr 19, 2024 $34.09 $34.81 $33.63 $34.72 944 326
Apr 18, 2024 $33.42 $34.46 $32.61 $34.29 787 908
Apr 17, 2024 $33.73 $33.91 $32.80 $33.45 515 940
Apr 16, 2024 $34.24 $34.55 $33.41 $33.44 483 931
Apr 15, 2024 $36.78 $37.00 $34.09 $34.72 649 030
Apr 12, 2024 $36.89 $38.56 $35.53 $36.29 846 195
Apr 11, 2024 $39.12 $39.20 $37.03 $37.26 1 056 569
Apr 10, 2024 $36.53 $36.86 $35.78 $36.73 438 235
Apr 09, 2024 $37.91 $38.97 $37.52 $38.08 420 434
Apr 08, 2024 $37.83 $37.98 $37.23 $37.65 287 942
Apr 05, 2024 $37.74 $38.17 $37.15 $37.44 396 160
Apr 04, 2024 $39.31 $39.39 $37.68 $37.90 796 807
Apr 03, 2024 $38.56 $39.58 $38.42 $38.59 423 467
Apr 02, 2024 $39.35 $40.16 $38.68 $39.04 603 276
Apr 01, 2024 $41.34 $41.34 $39.97 $40.40 342 539
Click to get the best stock tips daily for free!

About Arvinas Inc.

Arvinas. Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV... ARVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT